alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats.
about
Axonal α7 nicotinic ACh receptors modulate presynaptic NMDA receptor expression and structural plasticity of glutamatergic presynaptic boutonsDendritic spine alterations in the hippocampus and parietal cortex of alpha7 nicotinic acetylcholine receptor knockout miceNature's bounty - drug discovery from the seaα7nAchR/NMDAR coupling affects NMDAR function and object recognition.Computational identification of potential multitarget treatments for ameliorating the adverse effects of amyloid-β on synaptic plasticityNicotine: specific role in angiogenesis, proliferation and apoptosis.Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.Endogenously released ACh and exogenous nicotine differentially facilitate long-term potentiation induction in the hippocampal CA1 region of mice.Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.Prenatal choline supplementation alters the timing, emotion, and memory performance (TEMP) of adult male and female rats as indexed by differential reinforcement of low-rate schedule behavior.CHRNA7 Polymorphisms and Dementia Risk: Interactions with Apolipoprotein ε4 and Cigarette Smoking.Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.Consequences of inhibiting amyloid precursor protein processing enzymes on synaptic function and plasticity.Targeting synaptic dysfunction in Alzheimer's disease therapy.Possible contributions of a novel form of synaptic plasticity in Aplysia to reward, memory, and their dysfunctions in mammalian brain.GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease.Beta-amyloid oligomers: recent developments.Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.Visualization of co-localization in Aβ42-administered neuroblastoma cells reveals lysosome damage and autophagosome accumulation related to cell death.The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptor.Effects of soluble β-amyloid on the release of neurotransmitters from rat brain synaptosomes.Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus.Differing time dependencies of object recognition memory impairments produced by nicotinic and muscarinic cholinergic antagonism in perirhinal cortex.α7 nicotinic ACh receptor-deficient mice exhibit sustained attention impairments that are reversed by β2 nicotinic ACh receptor activation.The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells.The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials.Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist.Amyloid β-protein suppressed nicotinic acetylcholine receptor-mediated currents in acutely isolated rat hippocampal CA1 pyramidal neurons.Small Aβ1-42 oligomer-induced membrane depolarization of neuronal and microglial cells: role of N-methyl-D-aspartate receptors.Intraneuronally injected amyloid β inhibits long-term potentiation in rat hippocampal slices.The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens.Requirement of α7 nicotinic acetylcholine receptors for amyloid β protein-induced depression of hippocampal long-term potentiation in CA1 region of rats in vivo.Simvastatin Enhances Spatial Memory and Long-Term Potentiation in Hippocampal CA1 via Upregulation of α7 Nicotinic Acetylcholine Receptor.Deficits in cognitive function and hippocampal plasticity in GM2/GD2 synthase knockout mice.Use of behavioural and long-term potentiation models in the development of memory-improving drugs.Simvastatin Enhances Activity and Trafficking of α7 Nicotinic Acetylcholine Receptor in Hippocampal Neurons Through PKC and CaMKII Signaling Pathways.
P2860
Q24601769-541BD396-5D68-4736-8120-17062F0576D9Q28594309-8BD44610-963D-432A-8857-435C18638353Q28828257-16B4AACF-8832-4757-AB43-16D751D4DC0FQ30561237-11F74BFB-CD89-406E-8E37-E7B1DAD99377Q33611723-A76F3CCB-56AA-425F-AD5C-C9B271348BF7Q34229828-A8F03578-9B29-4427-B208-995E858A3649Q34459388-DB2B726F-B31C-4971-88A1-AE44BE26F8FEQ35946508-A821D4F0-D872-4FC2-8CD3-605578822E27Q36464551-1765386E-5138-41C9-A0C7-7989934E6C9CQ36510447-2E736EF9-70AD-4A50-AC1C-983BBED2F9A1Q36959844-5DC7B7F5-6C22-4C29-BEF9-41913FCFE6A3Q37350693-CED4B425-9E24-428C-8947-4A5D48E8429DQ38026045-86BB91F1-316C-4C91-B62C-2C4391609252Q38036916-334A47A1-02B4-4525-BB83-98917797833DQ38139358-3C317A6C-1F48-4BEA-AF8A-39B6C31CCA2FQ38225536-1470570B-E80C-4BF7-AA27-431A83FADA46Q38281324-07F1C8BC-8860-43EF-96D4-7FBC552DD415Q38472553-F8FC6CE0-5137-4EA2-899C-0F524523B0C4Q38632327-68D0FB49-ED31-4F93-B969-FDAE7FDE534CQ39466630-859360AA-DF34-436F-B9DA-CEB335D0F2F6Q40173639-CF5DEE36-D299-4844-8998-8FA2DF0B1F89Q41808953-4CB32939-05E9-4206-8658-7A71F682B8ABQ41961835-4C3A6CFA-2CD5-4A87-98DD-DCA3AE997A2EQ42130851-40732981-D9CA-4B69-ADC2-FD2B4C8ABCDDQ42176718-D70D9C37-0269-4C71-8EFD-06497AF8AC7CQ45931909-895F4031-93D5-4D6C-B7C8-7308B8315B2AQ47127039-61FF5E94-DC09-43B4-8575-37295914A216Q48252803-9FC6D494-79E4-4258-95E2-A175D7628B56Q48362099-7A1091F3-E324-4B15-B027-C5BD93D7C116Q48455427-2F3A0B05-F7FB-4DD1-9127-8E27FED3EF0AQ48658737-E28B8E1A-CDCE-48C0-8BD0-3F842A54322BQ48785714-AA281BFF-C08A-458F-9BC4-949C85A92F32Q48869887-AA234274-C0C2-47CE-8068-89CB39D94138Q50576727-F7E0C37D-F832-4D87-A5E5-EB5AC8D9CB04Q50667993-CB332E80-3FCC-44E7-AB99-B594119E3CB7Q51962312-621FF2C7-D8AE-4766-A497-F87A88821C92Q54980049-0F24505D-B89E-4226-A81F-66CDCB732673
P2860
alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
alpha7 Nicotinic acetylcholine ...... in beta-amyloid infused rats.
@en
alpha7 Nicotinic acetylcholine ...... in beta-amyloid infused rats.
@nl
type
label
alpha7 Nicotinic acetylcholine ...... in beta-amyloid infused rats.
@en
alpha7 Nicotinic acetylcholine ...... in beta-amyloid infused rats.
@nl
prefLabel
alpha7 Nicotinic acetylcholine ...... in beta-amyloid infused rats.
@en
alpha7 Nicotinic acetylcholine ...... in beta-amyloid infused rats.
@nl
P2093
P1433
P1476
alpha7 Nicotinic acetylcholine ...... in beta-amyloid infused rats.
@en
P2093
Kiyofumi Yamada
Masahiro Sokabe
Toshitaka Nabeshima
P304
P356
10.1016/J.NEUROPHARM.2005.09.018
P577
2005-12-01T00:00:00Z